The Alpha DaRT Treatment
Alpha DaRT enables a highly potent and conformal radiation treatment for solid cancer tumors. Directly inserted into the tumor, the Alpha DaRT sources release a high-energy dose over a range of several millimeters enabling a focal alpha-radiation treatment that spares the surrounding healthy tissue. The Alpha DaRT treatment has several significant clinical advantages…
Alpha Tau Medical is currently running clinical trials for:
- Skin Cancer
- Oral Cavity Cancer
- Prostate Cancer
- Pancreatic Cancer
- Breast Cancer
The company is working with leading cancer researchers to commence additional trials for further indications.
About Alpha Tau Medical
Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.